Bronx-Lebanon Hosp. IMPAACT CRS

The Bronx, New York 10457

0 studies enrolling now · 25 studies all time

What they study most

Cervix, Dysplasia, Dyslipidemia, HIV Infections, HIV Lipodystrophy Syndrome, HIV Seronegativity, HIV-Associated Lipodystrophy Syndrome, Hepatitis B, Influenza, Lipodystrophy, Measles, Mycobacterium Avium-intracellulare Infection, Osteopenia

Studies at this site

• Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents — Completed
• A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT — Completed
• A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women — Completed
• A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers — Completed
• A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection — Completed
• Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children — Completed
• Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants — Completed
• Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs — Completed
• Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy — Completed
• Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants — Completed
• Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs — Completed
• Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents — Completed
• The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients — Completed
• Growth Hormone Treatment of Children With HIV-Associated Growth Failure — Completed
• Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children — Completed
• A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine — Completed
• The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children — Completed
• A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants — Completed
• A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women — Completed
• A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT — Completed
• A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth — Completed
• Blood Levels of Abacavir in HIV Infected Adolescents — Completed
• Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents — Completed
• The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV — Completed
• Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents — Completed